An evaluation of the beta-1 adrenergic receptor Arg389Gly polymorphism in individuals with heart failure: a MERIT-HF sub-study.
about
Pharmacogenetics of beta-blockersPharmacogenetics in chronic heart failure: new developments and current challengesPharmacogenetics and anaesthesia: the value of genetic profilingPharmacogenomics and cardiovascular diseaseCombinatorial pharmacogenetic interactions of bucindolol and β1, α2C adrenergic receptor polymorphismsPharmacogenomics of beta1-adrenergic receptor polymorphisms in heart failure.β1 adrenergic receptor polymorphisms and heart failure: a meta-analysis on susceptibility, response to β-blocker therapy and prognosisRAAS and adrenergic genes in heart failure: Function, predisposition and survival implicationsBeta 1- and beta 2-adrenoceptor polymorphisms and cardiovascular diseases.Association of beta-adrenergic receptor polymorphisms and mortality in carvedilol-treated chronic heart-failure patientsA polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failureThe genomic architecture of sporadic heart failurePharmacogenomics in heart failure: where are we now and how can we reach clinical application?Bucindolol: a pharmacogenomic perspective on its use in chronic heart failureEffects of GRK5 and ADRB1 polymorphisms influence on systolic heart failureGenetics and heart failure: a concise guide for the clinicianA common β1-adrenergic receptor polymorphism predicts favorable response to rate-control therapy in atrial fibrillation.The functional significance of genetic variation within the beta-adrenoceptor.A case for pharmacogenomics in management of cardiac arrhythmias.Clinical trials update from the Heart Failure Society of America: EMOTE, HERB-CHF, BEST genetic sub-study and RHYTHM-ICD.Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillationThe role of adrenergic receptor polymorphisms in heart failure.Impact of the β-1 adrenergic receptor polymorphism on tolerability and efficacy of bisoprolol therapy in Korean heart failure patients: association between β adrenergic receptor polymorphism and bisoprolol therapy in heart failure (ABBA) studyGenetics in heart failure: where are we headed?Association between adrenergic receptor genotypes and beta-blocker dose in heart failure patients: analysis from the HF-ACTION DNA substudy.Role of beta adrenergic receptor polymorphisms in heart failure: systematic review and meta-analysis.Beta1- and beta2-adrenoceptor polymorphisms and cardiovascular diseases.Prevention of atrial fibrillation by bucindolol is dependent on the beta₁389 Arg/Gly adrenergic receptor polymorphism.Mechanisms of pharmacogenomic effects of genetic variation within the cardiac adrenergic network in heart failureAdrenergic nervous system in heart failure: pathophysiology and therapy.Clinical and genetic modifiers of long-term survival in heart failure.Beta-1-adrenoceptor genetic variants and ethnicity independently affect response to beta-blockade.Pharmacogenetics in heart failure: promises and challenges.Genetics and genomics of dilated cardiomyopathy and systolic heart failure.Alpha-1-adrenergic receptors in heart failure: the adaptive arm of the cardiac response to chronic catecholamine stimulation.Nebivolol in chronic heart failure: current evidence and future perspectives.Pharmacogenomics of beta-adrenergic receptors and their accessory signaling proteins in heart failure.Adrenergic signaling polymorphisms and their impact on cardiovascular disease.Heart failure pharmacogenetics: past, present, and future.Future of personalized pharmacotherapy in chronic heart failure patients.
P2860
Q24644448-B3D0FD82-59B8-410A-83C0-1CBB0B703BB7Q26852239-9B0FCC24-E581-4A9B-B4BB-8DE96542A35FQ26859221-A2F3232D-9FD8-4344-954B-615C7F21FC01Q26997380-92DCE8A5-6D08-47F5-964D-0618857AA019Q28484344-093ACB40-57C6-451E-94D5-03DD5B0E2372Q33671687-E804765C-ADF0-4E6F-953B-2F6724FE3AC1Q34344600-D90BD2F7-9552-47D9-92DC-D664C17C26F1Q34390058-107F1572-8359-47F2-8F83-4FF3AFB6F573Q34658477-27391F20-EBB1-45F6-A476-6455B5A7EDB5Q34830038-26DC926E-29BC-43B9-BB50-DD6E3D70456FQ34872068-4CB8D091-C131-4143-8075-AC12898244F6Q35033305-6B4F7C4B-621F-4E0F-89FF-CA0F7B82EE61Q35086882-CDB07DBF-9F77-4AED-B2E6-7511AE9737BDQ35117742-3B677F42-D3E1-4207-B10C-D703841D00D0Q35132889-E6342A97-A1DE-4ED6-8F48-1B64B03CED0DQ35139937-E5FA4740-D59A-4E2D-8D82-48A9BA3EA620Q35633271-4151EA84-A9E5-4BD7-AC6E-C96D1D50F936Q35826772-9E49FDB0-56EB-4D7E-8368-D8B950AE26F1Q35914690-B493C43E-2B52-41BF-8DFC-29DB2A0AAA3CQ35958237-0ECECBCE-800E-4A79-8D92-DB58DF96CCCBQ36623045-8FF678CD-72F7-45E4-B0E9-888B9FD07395Q36629879-B20BB80D-C533-4C5E-911D-AF8F05E53599Q36638124-1F07264E-6BFE-43C3-BB23-45FD2B8A51EEQ36684760-BB47E9F6-4056-4313-B160-CD029AC07D9DQ36999999-0302F450-8CE1-478C-8E64-C1252B47E13EQ37044831-517801D6-1F72-4098-9D47-B90FFB9AD754Q37114101-B3C28ABC-122B-4C15-9CC5-0E71BDA8E1E5Q37245081-3EC5F490-3B63-42C2-8A8C-5A79582720FAQ37314365-B0B3AA67-0960-4A76-A38E-F32A29A2B910Q37349756-63E8A9FE-0459-4254-A041-237801AD0D7CQ37358823-D09F2A5D-9378-463A-82D5-7A40ACD0113EQ37375138-FE5FC790-8787-424E-A9A9-84DFF1BAFDC0Q37532571-4706F611-ED29-4221-B726-9884C0175378Q37661546-D2567492-8FB4-4D30-98EB-75CB6CFDEFD8Q37692816-A8CB8B0D-D022-4741-9829-F3E0D0A702E8Q37716016-73EDC917-D9D4-4655-9A9F-57E385C9CB52Q37742683-57FAB288-A258-44C1-A9C2-1695EC963DCFQ37776088-4AD46F47-C130-487E-BC82-08C29A3ECCEFQ37854508-D5FCC1E5-0032-49A1-8352-8A7FD8CB52E0Q37882710-2BEC79E3-8CA1-47C3-A40A-23BD3C7A0CA8
P2860
An evaluation of the beta-1 adrenergic receptor Arg389Gly polymorphism in individuals with heart failure: a MERIT-HF sub-study.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
An evaluation of the beta-1 ad ...... failure: a MERIT-HF sub-study.
@en
An evaluation of the beta-1 ad ...... failure: a MERIT-HF sub-study.
@en-gb
An evaluation of the beta-1 ad ...... failure: a MERIT-HF sub-study.
@nl
type
label
An evaluation of the beta-1 ad ...... failure: a MERIT-HF sub-study.
@en
An evaluation of the beta-1 ad ...... failure: a MERIT-HF sub-study.
@en-gb
An evaluation of the beta-1 ad ...... failure: a MERIT-HF sub-study.
@nl
prefLabel
An evaluation of the beta-1 ad ...... failure: a MERIT-HF sub-study.
@en
An evaluation of the beta-1 ad ...... failure: a MERIT-HF sub-study.
@en-gb
An evaluation of the beta-1 ad ...... failure: a MERIT-HF sub-study.
@nl
P2093
P2860
P50
P1476
An evaluation of the beta-1 ad ...... failure: a MERIT-HF sub-study.
@en
P2093
Anthony J Balmforth
Azhar Maqbool
Hazel L White
MERIT-HF Study Group
Richard Cuthbert
Rudolf A de Boer
Stephen G Ball
P2860
P304
P356
10.1016/S1388-9842(03)00044-8
P577
2003-08-01T00:00:00Z